Neo Ivy Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Neo Ivy Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,421	Closed	-$698K	–	495
2026 Q1	$698K	Sell	1,421 -9,671	-87%	-$5.25M	0.18%	180
2025 Q4	$6.43M	Buy	11,092 +6,320	+132%	+$3.57M	1.02%	12
2025 Q3	$2.31M	Buy	4,772 +3,865	+426%	+$1.8M	0.56%	56
2025 Q2	$368K	Buy	+907	New	+$379K	0.12%	234
2021 Q2	–	Sell	-610	Closed	-$278K	–	610
2021 Q1	$278K	Sell	610 -37	-6%	-$17.7K	0.3%	115
2020 Q4	$301K	Buy	+647	New	+$303K	0.34%	104
2020 Q2	–	Sell	-1,775	Closed	-$503K	–	598
2020 Q1	$503K	Buy	+1,775	New	+$560K	0.82%	7

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Neo Ivy Capital Management's TMO Position: Q2 2026 in Review

Neo Ivy Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 1,421 shares — an estimated $698K sold.

Neo Ivy Capital Management first reported a position in TMO in Q1 2020 and held it in 7 quarters. The position peaked at $6.43M in Q4 2025. 2,628 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Neo Ivy Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
Neo Ivy Capital Management sold 1,421 Thermo Fisher Scientific shares in Q2 2026, an estimated $698K.
Neo Ivy Capital Management first reported a position in Thermo Fisher Scientific in Q1 2020 and held it in 7 quarters.
Neo Ivy Capital Management's Thermo Fisher Scientific position peaked at $6.43M in Q4 2025.
2,628 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.